As mentioned in our email to you regarding new opportunities for NMR especially for 600 MHz users, we want to give more details.
As you probably are aware, Human metabolomics has seen a rapid rise in the world of Omics and currently is a major source of funding in many countries worldwide. NMR is one of the 2 main tools in Metabolomics, highly synergistic to mass spectrometry, which is the other tool in use.
At Bruker we have developed a standardized approach to generate high quality spectra of human bodyfluids and analysis of the spectra in terms of quantification from the mixture spectra and also statistical analysis. This is all centered on our IVDr platform and covers currently Urine, Plasma, Serum, CSF and Methanol extracts (from bodyfluids, tissues, cells).
As you can see from below, the complete solution is consisting of 4 levels. Level 1 and 2 are requirements to use the enabling tools and assays in level 3 and 4. In level 4 the grey and yellow boxes describe collaborative developments with partners currently in progress. Everything listed in the blue boxes is available for ordering. Detailed descriptions can be obtained clicking on the boxes.
We have a base of more than 75 users worldwide working with our standards already and such creating exchangeable spectra for large scale epidemiology research or clinical trials. Amongst those users are also hospitals, biobanks and the members of the International Phenome Center Network (IPCN).